Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 231

1.

Endometriosis-associated pain scores and biomarkers in users of the etonogestrel-releasing subdermal implant or the 52-mg levonorgestrel-releasing intrauterine system for up to 24 months.

Margatho D, Carvalho NM, Bahamondes L.

Eur J Contracept Reprod Health Care. 2020 Apr;25(2):133-140. doi: 10.1080/13625187.2020.1725461. Epub 2020 Feb 18.

PMID:
32069126
2.

Long-acting reversible contraceptive (LARCs) methods.

Bahamondes L, Fernandes A, Monteiro I, Bahamondes MV.

Best Pract Res Clin Obstet Gynaecol. 2019 Dec 20. pii: S1521-6934(19)30178-6. doi: 10.1016/j.bpobgyn.2019.12.002. [Epub ahead of print] Review.

PMID:
32014434
3.

The benefits and limitations of donating new contraceptive technology: The case of the International Contraceptive Access (ICA) Foundation and the LNG IUS Program in Brazil.

Miranda L, Townsend J, Faúndes A, Bahamondes L.

Contraception. 2020 Jan 31. pii: S0010-7824(20)30003-2. doi: 10.1016/j.contraception.2020.01.003. [Epub ahead of print] No abstract available.

PMID:
32007419
4.

Lack of Influence of Thyroid Hormone on Bone Mineral Density and Body Composition in Healthy Euthyroid Women.

Zantut-Wittmann DE, Quintino-Moro A, Dos Santos PNS, Melhado-Kimura V, Bahamondes L, Fernandes A.

Front Endocrinol (Lausanne). 2020 Jan 10;10:890. doi: 10.3389/fendo.2019.00890. eCollection 2019.

5.

Levonorgestrel-releasing intrauterine system and breast cancer risk: A systematic review and meta-analysis.

Conz L, Mota BS, Bahamondes L, Teixeira Dória M, Françoise Mauricette Derchain S, Rieira R, Sarian LO.

Acta Obstet Gynecol Scand. 2020 Jan 28. doi: 10.1111/aogs.13817. [Epub ahead of print] Review.

PMID:
31990981
6.

Postplacental placement of intrauterine devices: A randomized clinical trial.

Laporte M, Marangoni M Jr, Surita F, Juliato CT, Miadaira M, Bahamondes L.

Contraception. 2020 Mar;101(3):153-158. doi: 10.1016/j.contraception.2019.12.006. Epub 2020 Jan 9.

PMID:
31927027
7.

A randomized controlled pilot study of ulipristal acetate for abnormal bleeding among women using the 52-mg levonorgestrel intrauterine system.

Fava M, Peloggia A, Baccaro LF, Castro S, Carvalho N, Bahamondes L.

Int J Gynaecol Obstet. 2020 Apr;149(1):10-15. doi: 10.1002/ijgo.13068. Epub 2019 Dec 11.

PMID:
31777949
8.

Mechanisms involved in the contraceptive effects of ulipristal acetate.

Munuce MJ, Gómez-Elías MD, Caille AM, Bahamondes L, Cuasnicú PS, Cohen DJ.

Reproduction. 2020 Mar;159(3):R139-R149. doi: 10.1530/REP-19-0355. Review.

PMID:
31689233
9.

Intracervical block for levonorgestrel-releasing intrauterine system placement among nulligravid women: a randomized double-blind controlled trial.

De Nadai MN, Poli-Neto OB, Franceschini SA, Yamaguti EMM, Monteiro IMU, Troncon JK, Juliato CRT, Santana LF, Bahamondes L, Vieira CS.

Am J Obstet Gynecol. 2020 Mar;222(3):245.e1-245.e10. doi: 10.1016/j.ajog.2019.09.013. Epub 2019 Sep 18.

PMID:
31541635
10.

Changes in calcium metabolism and bone mineral density in new users of medroxyprogesterone acetate during the first year of use.

Quintino-Moro A, Zantut-Wittmann DE, Silva Dos Santos PN, Silva CA, Bahamondes L, Fernandes A.

Int J Gynaecol Obstet. 2019 Dec;147(3):319-325. doi: 10.1002/ijgo.12958. Epub 2019 Sep 20.

PMID:
31479152
11.

Bleeding profile associated with 1-year use of the segesterone acetate/ethinyl estradiol contraceptive vaginal system: pooled analysis from Phase 3 trials.

Vieira CS, Fraser IS, Plagianos MG, Burke AE, Westhoff CL, Jensen J, Brache V, Bahamondes L, Merkatz R, Sitruk-Ware R, Blithe DL.

Contraception. 2019 Dec;100(6):438-444. doi: 10.1016/j.contraception.2019.07.145. Epub 2019 Aug 6.

PMID:
31398307
12.

Efficacy of the 1-year (13-cycle) segesterone acetate and ethinylestradiol contraceptive vaginal system: results of two multicentre, open-label, single-arm, phase 3 trials.

Archer DF, Merkatz RB, Bahamondes L, Westhoff CL, Darney P, Apter D, Jensen JT, Brache V, Nelson AL, Banks E, Bártfai G, Portman DJ, Plagianos M, Dart C, Kumar N, Creasy GW, Sitruk-Ware R, Blithe DL.

Lancet Glob Health. 2019 Aug;7(8):e1054-e1064. doi: 10.1016/S2214-109X(19)30265-7. Epub 2019 Jun 20.

13.

Interventions for the prevention of pain associated with the placement of intrauterine contraceptives: An updated review.

Gemzell-Danielsson K, Jensen JT, Monteiro I, Peers T, Rodriguez M, Di Spiezio Sardo A, Bahamondes L.

Acta Obstet Gynecol Scand. 2019 Dec;98(12):1500-1513. doi: 10.1111/aogs.13662. Epub 2019 Jun 27. Review.

14.

Modern contraceptives in sub-Saharan African countries.

Bahamondes L, Peloggia A.

Lancet Glob Health. 2019 Jul;7(7):e819-e820. doi: 10.1016/S2214-109X(19)30199-8. Epub 2019 May 17. No abstract available.

15.

Disease activity and thromboembolic events in women with systemic lupus erythematosus with and without anti-phospholipid syndrome: users of the 52-mg levonorgestrel-releasing intrauterine system.

Rebelo RC, Pignaton E, Valeria Bahamondes M, Costallat LTL, Appenzeller S, Bahamondes L, Fernandes A.

Arch Gynecol Obstet. 2019 Jun;299(6):1597-1605. doi: 10.1007/s00404-019-05131-x. Epub 2019 Apr 2.

PMID:
30941559
16.

Sexual Function and Quality of Life in a Cohort of Brazilian Users of Two Kind of Intrauterine Contraceptives.

Ferreira JM, Carreiro AV, Fernandes A, Bahamondes L.

Rev Bras Ginecol Obstet. 2019 Apr;41(4):236-241. doi: 10.1055/s-0039-1683370. Epub 2019 Mar 25.

17.

Follow-up visits to check strings after intrauterine contraceptive placement cannot predict or prevent future expulsion.

Bahamondes L, Monteiro I, Fernandes A, Gaffield ME.

Eur J Contracept Reprod Health Care. 2019 Apr;24(2):97-101. doi: 10.1080/13625187.2019.1586872. Epub 2019 Mar 14.

PMID:
30870042
18.

A single post-ovulatory dose of ulipristal acetate impairs post-fertilization events in mice.

Gómez-Elías MD, May M, Munuce MJ, Bahamondes L, Cuasnicú PS, Cohen DJ.

Mol Hum Reprod. 2019 May 1;25(5):257-264. doi: 10.1093/molehr/gaz013.

PMID:
30824928
19.

Thyroid function during the first year of use of the injectable contraceptive depot medroxyprogesterone acetate.

Quintino-Moro A, Zantut-Wittmann DE, Silva Dos Santos PN, Melhado-Kimura V, da Silva CA, Bahamondes L, Fernandes A.

Eur J Contracept Reprod Health Care. 2019 Apr;24(2):102-108. doi: 10.1080/13625187.2018.1559284. Epub 2019 Feb 5.

PMID:
30721635
20.

Control of endometriosis-associated pain with etonogestrel-releasing contraceptive implant and 52-mg levonorgestrel-releasing intrauterine system: randomized clinical trial.

Carvalho N, Margatho D, Cursino K, Benetti-Pinto CL, Bahamondes L.

Fertil Steril. 2018 Nov;110(6):1129-1136. doi: 10.1016/j.fertnstert.2018.07.003.

PMID:
30396557
21.

Assessment of biomarkers in women with endometriosis-associated pain using the ENG contraceptive implant or the 52 mg LNG-IUS: a non-inferiority randomised clinical trial.

Margatho D, Mota Carvalho N, Eloy L, Bahamondes L.

Eur J Contracept Reprod Health Care. 2018 Oct;23(5):344-350. doi: 10.1080/13625187.2018.1531117. Epub 2018 Oct 29.

PMID:
30372645
22.

Long term social consequences of adolescent pregnancy.

Bahamondes L.

BJOG. 2019 Feb;126(3):368. doi: 10.1111/1471-0528.15488. Epub 2018 Nov 5. No abstract available.

23.

Advances in contraceptive vaginal rings: what does the future hold?

Monteiro I, Guazzelli CF, Bahamondes L.

Expert Opin Pharmacother. 2018 Oct;19(15):1685-1691. doi: 10.1080/14656566.2018.1519549. Epub 2018 Oct 5. Review.

PMID:
30286682
24.

Zika virus exposure in pregnancy and its association with newborn visual anomalies and hearing loss.

Peloggia A, Ali M, Nanda K, Bahamondes L.

Int J Gynaecol Obstet. 2018 Dec;143(3):277-281. doi: 10.1002/ijgo.12663. Epub 2018 Sep 24. Review.

PMID:
30191558
25.

A multicenter randomized clinical trial of etonogestrel and levonorgestrel contraceptive implants with nonrandomized copper intrauterine device controls: effect on weight variations up to 3 years after placement.

Bahamondes L, Brache V, Ali M, Habib N; WHO study group on contraceptive implants for women.

Contraception. 2018 Sep;98(3):181-187. doi: 10.1016/j.contraception.2018.05.009. Epub 2018 May 16.

PMID:
29777663
26.

A case series on the use of levonorgestrel 52 mg intrauterine system after organ transplant.

Juliato CRT, Stahlschmidt P, Fernandes A, Monteiro I, Bahamondes L.

Contraception. 2018 Sep;98(3):252-254. doi: 10.1016/j.contraception.2018.04.017. Epub 2018 May 7.

PMID:
29746814
27.

Dietary intake and eating behavior in depot medroxyprogesterone acetate users: a systematic review.

Silva P, Qadir S, Fernandes A, Bahamondes L, Peipert JF.

Braz J Med Biol Res. 2018;51(6):e7575. doi: 10.1590/1414-431x20187575. Epub 2018 Apr 23. Review.

28.

Subclinical cardiovascular disease parameters after one year in new users of depot medroxyprogesterone acetate compared to copper-IUD.

Cursino K, de Lima GA, de Nazaré Silva Dos Santos P, Pavin EJ, Bahamondes L, Fernandes A.

Eur J Contracept Reprod Health Care. 2018 Jun;23(3):201-206. doi: 10.1080/13625187.2018.1455087. Epub 2018 Apr 19.

PMID:
29671344
29.

Hyperinsulinemic-euglycemic clamp over the first year of use of depot-medroxyprogesterone acetate as a contraceptive.

Melhado-Kimura V, Batista GA, de Souza AL, Silva Dos Santos PN, Alegre SM, Pavin EJ, Bahamondes L, Fernandes A.

Contraception. 2018 Apr 14. pii: S0010-7824(18)30139-2. doi: 10.1016/j.contraception.2018.04.003. [Epub ahead of print]

PMID:
29665358
30.

The use of long-acting reversible contraceptives in Latin America and the Caribbean: current landscape and recommendations.

Bahamondes L, Villarroel C, Frías Guzmán N, Oizerovich S, Velázquez-Ramírez N, Monteiro I.

Hum Reprod Open. 2018 Jan 23;2018(1):hox030. doi: 10.1093/hropen/hox030. eCollection 2018.

31.

Extended Effectiveness of the Etonogestrel-Releasing Contraceptive Implant and the 20 µg Levonorgestrel-Releasing Intrauterine System for 2 Years Beyond U.S. Food and Drug Administration Product Labeling.

Ali M, Bahamondes L, Bent Landoulsi S.

Glob Health Sci Pract. 2017 Dec 28;5(4):534-539. doi: 10.9745/GHSP-D-17-00296. Print 2017 Dec 28. No abstract available.

32.

Stagnant contraceptive sales after the Zika epidemic in Brazil.

Bahamondes L, Ali M, Monteiro I, Fernandes A.

Eur J Contracept Reprod Health Care. 2017 Oct;22(5):381-383. doi: 10.1080/13625187.2017.1397623. Epub 2017 Nov 23.

PMID:
29166843
33.

Pregnancy outcomes associated with extended use of the 52-mg 20 μg/day levonorgestrel-releasing intrauterine system beyond 60 months: A chart review of 776 women in Brazil.

Bahamondes L, Fernandes A, Bahamondes MV, Juliato CT, Ali M, Monteiro I.

Contraception. 2018 Mar;97(3):205-209. doi: 10.1016/j.contraception.2017.10.007. Epub 2017 Oct 18.

PMID:
29055780
34.

Sperm chemorepulsion, a supplementary mechanism to regulate fertilization.

Guidobaldi HA, Cubilla M, Moreno A, Molino MV, Bahamondes L, Giojalas LC.

Hum Reprod. 2017 Aug 1;32(8):1560-1573. doi: 10.1093/humrep/dex232.

PMID:
28854585
35.

Relationship between user satisfaction with the levonorgestrel-releasing intrauterine system and bleeding patterns.

Carvalho NM, Chou V, Modesto W, Margatho D, Garcia EAL, Bahamondes L.

J Obstet Gynaecol Res. 2017 Nov;43(11):1732-1737. doi: 10.1111/jog.13441. Epub 2017 Aug 17.

PMID:
28833891
36.

Barriers to Implementing and Consolidating a Family Planning Program that would meet Brazilian Needs.

Bahamondes L, Fernandes A, Monteiro I.

Rev Bras Ginecol Obstet. 2017 Aug;39(8):373-375. doi: 10.1055/s-0037-1604423. Epub 2017 Aug 3. No abstract available.

37.

Effect of the injectable contraceptive depot-medroxyprogesterone acetate on coagulation parameters in new users.

Melhado-Kimura V, Bizzacchi JMA, Quaino SKP, Montalvao S, Bahamondes L, Fernandes A.

J Obstet Gynaecol Res. 2017 Jun;43(6):1054-1060. doi: 10.1111/jog.13306. Epub 2017 May 15.

PMID:
28503774
38.

Estimated disability-adjusted life years averted by free-of-charge provision of the levonorgestrel-releasing intrauterine system over a 9-year period in Brazil.

Ferreira JM, Monteiro I, Fernandes A, Bahamondes MV, Pitoli A, Bahamondes L.

J Fam Plann Reprod Health Care. 2017 Jul;43(3):181-185. doi: 10.1136/jfprhc-2016-101569. Epub 2017 Mar 22.

39.

Study of the effect of ulipristal acetate on human sperm ability to interact with tubal tissue and cumulus-oocyte-complexes.

Zumoffen C, Gómez-Elías MD, Caille AM, Bahamondes L, Cuasnicú PS, Cohen DJ, Munuce MJ.

Contraception. 2017 Jun;95(6):586-591. doi: 10.1016/j.contraception.2017.02.019. Epub 2017 Feb 24.

PMID:
28238840
40.

Comments on manuscript: vaginal misoprostol prior to intrauterine device insertion in women delivered only by elective cesarean section: a randomized double-blind clinical trial.

Bahamondes L, Monteiro I.

Contraception. 2017 Apr;95(4):434-435. doi: 10.1016/j.contraception.2017.01.012. Epub 2017 Feb 7. No abstract available.

PMID:
28189667
41.

Contraceptive sales in the setting of the Zika virus epidemic.

Bahamondes L, Ali M, Monteiro I, Fernandes A.

Hum Reprod. 2017 Jan;32(1):88-93. Epub 2016 Dec 7.

42.

The Practice of Hatha Yoga for the Treatment of Pain Associated with Endometriosis.

Gonçalves AV, Barros NF, Bahamondes L.

J Altern Complement Med. 2017 Jan;23(1):45-52. doi: 10.1089/acm.2015.0343. Epub 2016 Nov 21.

PMID:
27869485
43.

Binge eating and biochemical markers of appetite in new users of the contraceptive depot medroxyprogesterone acetate.

Silva Dos Santos PN, de Souza AL, Batista GA, Melhado-Kimura V, de Lima GA, Bahamondes L, Fernandes A.

Arch Gynecol Obstet. 2016 Nov;294(6):1331-1336. Epub 2016 Sep 7.

PMID:
27604241
44.

Advantages of self-administration of injectable contraceptives.

Bahamondes L.

BJOG. 2017 Jan;124(2):209. doi: 10.1111/1471-0528.14301. Epub 2016 Oct 3. No abstract available.

45.

Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant.

Ali M, Akin A, Bahamondes L, Brache V, Habib N, Landoulsi S, Hubacher D; WHO study group on subdermal contraceptive implants for women.

Hum Reprod. 2016 Nov;31(11):2491-2498. Epub 2016 Sep 26.

46.

Knowledge of Latin American Obstetricians and Gynecologists regarding Heavy Menstrual Bleeding.

Bahamondes L, Marin V, Ciarmatori S, Silva-Filho AL, Acuña JM, Makuch MY.

Obstet Gynecol Int. 2016;2016:6870679. doi: 10.1155/2016/6870679. Epub 2016 Aug 25.

47.

A Qualitative Study on the Practice of Yoga for Women with Pain-Associated Endometriosis.

Gonçalves AV, Makuch MY, Setubal MS, Barros NF, Bahamondes L.

J Altern Complement Med. 2016 Dec;22(12):977-982. Epub 2016 Aug 23.

PMID:
27552065
48.

Comparison of two strategies for the administration of injectable depot medroxyprogesterone acetate: among women who returned to a family planning clinic at three- or six-month intervals.

Ferreira JM, Bottura BF, Gonçalves MP, Monteiro I, Bahamondes L.

Eur J Contracept Reprod Health Care. 2016 Oct;21(5):408-11. doi: 10.1080/13625187.2016.1217326. Epub 2016 Aug 17.

PMID:
27530899
49.

Sexual dysfunction risk and quality of life among women with a history of sexual abuse.

Carreiro AV, Micelli LP, Sousa MH, Bahamondes L, Fernandes A.

Int J Gynaecol Obstet. 2016 Sep;134(3):260-3. doi: 10.1016/j.ijgo.2016.01.024. Epub 2016 May 25.

PMID:
27350228
50.

Assessment of the quality of cervical mucus among users of the levonorgestrel-releasing intrauterine system at different times of use.

Moraes LG, Marchi NM, Pitoli AC, Hidalgo MM, Silveira C, Modesto W, Bahamondes L.

Eur J Contracept Reprod Health Care. 2016 Aug;21(4):318-22. doi: 10.1080/13625187.2016.1193139. Epub 2016 Jun 7.

PMID:
27269613

Supplemental Content

Loading ...
Support Center